Harringtonine has the effects of double blocking SARS-CoV-2 membrane fusion
S. Hu, N. Wang, S. Chen, Q. Ding, C. Wang, W. Ma, X. Zhang, Y. Wu, Y. Lv, Z. Xue, H. Bai, S. Ge, H. He, W. Lu, T. Zhang, , L. He
This study shows Harringtonine inhibits SARS-CoV-2 membrane fusion by targeting both the viral S protein and host TMPRSS2, effectively blocking infection in delta and Omicron variants.
bioRxiv · Jan 22, 2022 · PreprintPharmacology & Toxicology